Management of Hyperparathyroidism with Hypercalciuria
Initial Assessment and Diagnosis
- The American College of Cardiology is not mentioned, however, the management of hyperparathyroidism with elevated 24-hour urine calcium should focus on increasing active vitamin D and/or decreasing phosphate supplements, with consideration of calcimimetics or parathyroidectomy in refractory cases 1
- Measure serum calcium and intact parathyroid hormone (iPTH) simultaneously for accurate diagnosis of hyperparathyroidism 1
- Assess 25-OH vitamin D levels, aiming for levels >20 ng/ml (50 mmol/l) to rule out vitamin D deficiency as a contributing factor 2
- Evaluate dietary calcium intake through dietary assessment to ensure adequate intake 3
- Measure 24-hour urine calcium to quantify hypercalciuria and monitor treatment efficacy 4
Differential Diagnosis
- Secondary hyperparathyroidism is characterized by elevated PTH with normal or low serum calcium, often seen in chronic kidney disease or vitamin D deficiency 1
- Primary hyperparathyroidism is characterized by elevated PTH with high or high-normal serum calcium 1
- Tertiary hyperparathyroidism is persistent hypercalcemic hyperparathyroidism despite correction of the underlying cause 1
Management Algorithm
- For secondary hyperparathyroidism, increase active vitamin D (calcitriol or alfacalcidol) and/or decrease oral phosphate supplements 2
- Supplement with native vitamin D (cholecalciferol or ergocalciferol) if 25-OH vitamin D levels are below 20 ng/ml 2
- Ensure adequate dietary calcium intake according to age-related recommendations 5
- Implement measures to decrease urinary calcium concentration and crystallization, including regular water intake, administration of potassium citrate, and limited sodium intake 6
- Monitor urinary calcium levels regularly to assess treatment efficacy 4
- If hyperparathyroidism persists despite optimized vitamin D therapy and phosphate adjustment, consider calcimimetics (cinacalcet) 2
- Use cinacalcet with caution due to potential adverse effects including hypocalcemia and increased QT interval 2
- Consider parathyroidectomy for tertiary hyperparathyroidism (persistent hypercalcemic hyperparathyroidism) despite optimized medical therapy 2
- Parathyroidectomy is the only definitive cure for primary hyperparathyroidism and is recommended for patients with severe disease 1
Post-Treatment Monitoring
- Monitor serum calcium, PTH, and phosphate levels regularly to assess treatment response 3
- Check ionized calcium every 4-6 hours for the first 48-72 hours after parathyroidectomy 7
- After parathyroidectomy, calcium supplementation may be necessary to prevent hypocalcemia 7
- Adjust phosphate binders based on serum phosphorus levels 7
Special Considerations
- In patients with reduced kidney function (eGFR <60 ml/min/1.73 m²), carefully monitor serum phosphate levels 2
- For patients with normocalcemic hyperparathyroidism and hypercalciuria, the risk of renal complications should be considered 5
- In adult patients with mild hyperparathyroidism and persistent normocalcaemic hyperparathyroidism, active vitamin D might be given without phosphate supplements if careful follow-up is provided 5